Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nerve Pluss
- Development stage
- Unknown
- Lead developer
- Omega Remedies
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Nerve Pluss is a multi-ingredient nutraceutical product developed by Omega Remedies, designed to support nerve health and alleviate symptoms associated with neuropathy. The formulation typically includes methylcobalamin (an active form of Vitamin B12), alpha-lipoic acid (a potent antioxidant), pyridoxine (Vitamin B6), and folic acid. Methylcobalamin is crucial for the synthesis of the myelin sheath and promotes nerve regeneration. Alpha-lipoic acid helps mitigate oxidative stress, which is a significant contributor to nerve damage in conditions like diabetes. Pyridoxine and folic acid provide essential metabolic support for neural tissues. Nerve Pluss is positioned as a consumer wellness product for individuals experiencing peripheral or diabetic neuropathy.
- Brand names
- Nerve PlussNerve Plus
02
Targets
PDXK (Pyridoxal kinase)MTHFR (Methylenetetrahydrofolate reductase)MTR (Methionine synthase)
Beyond the preview
Go deeper on Nerve Pluss.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nerve Pluss.